Manulife (Manufacturers Life Insurance)
JBIO

Manulife (Manufacturers Life Insurance)’s Jade Biosciences JBIO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,012
Closed -$216K – 2818
2025
Q4 		$216K Buy
14,012
+2,940
+27% +$34.5K ﹤0.01% 2495
2025
Q3 		$95.6K Sell
11,072
-348
-3% -$2.84K ﹤0.01% 2786
2025
Q2 		$114K Buy
+11,420
New +$389K ﹤0.01% 2733

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s JBIO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Jade Biosciences (JBIO) in Q1 2026, closing a stake of 14,012 shares — an estimated $216K sold.

Manulife (Manufacturers Life Insurance) first reported a position in JBIO in Q2 2025 and held it in 3 quarters. The position peaked at $216K in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Jade Biosciences position as of Q1 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,012 Jade Biosciences shares in Q1 2026, an estimated $216K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Jade Biosciences in Q2 2025 and held it in 3 quarters.
  • Manulife (Manufacturers Life Insurance)'s Jade Biosciences position peaked at $216K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.